1887

Journal of Medical Microbiology logo

Volume 59, Issue 9

Characterization of leptospiral proteins that afford partial protection in hamsters against lethal challenge with Free

Abstract

Leptospirosis is a worldwide zoonosis caused by pathogenic The whole-genome sequence of serovar Copenhageni together with bioinformatic tools allow us to search for novel antigen candidates suitable for improved vaccines against leptospirosis. This study focused on three genes encoding conserved hypothetical proteins predicted to be exported to the outer membrane. The genes were amplified by PCR from six predominant pathogenic serovars in Brazil. The genes were cloned and expressed in strain BL21-SI using the expression vector pDEST17. The recombinant proteins tagged with N-terminal 6×His were purified by metal-charged chromatography. The proteins were recognized by antibodies present in sera from hamsters that were experimentally infected. Immunization of hamsters followed by challenge with a lethal dose of a virulent strain of showed that the recombinant protein rLIC12730 afforded statistically significant protection to animals (44 %), followed by rLIC10494 (40 %) and rLIC12922 (30 %). Immunization with these proteins produced an increase in antibody titres during subsequent boosters, suggesting the involvement of a T-helper 2 response. Although more studies are needed, these data suggest that rLIC12730 and rLIC10494 are promising candidates for a multivalent vaccine for the prevention of leptospirosis.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): CD, circular dichroism , CDS, coding sequence , HRP, horseradish peroxidase , LAg, leptospiral antigen , OMP, outer-membrane protein and Th, T helper
SGM
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.021485-0
2010-09-01
2024-04-25
Loading full text...

Full text loading...

/deliver/fulltext/jmm/59/9/1005.html?itemId=/content/journal/jmm/10.1099/jmm.0.021485-0&mimeType=html&fmt=ahah

References

  1. Adler B., de la Pena Moctezuma A. 2010; Leptospira and leptospirosis. Vet Microbiol 140:287–296 [CrossRef]
     [Google Scholar]
  2. Andrade M. A., Chacon P., Merelo J. J., Moran F. 1993; Evaluation of secondary structure of proteins from UV circular dichroism spectra using an unsupervised learning neural network. Protein Eng 6:383–390 [CrossRef]
     [Google Scholar]
  3. Bhandari P., Gowrishankar J. 1997; An Escherichia coli host strain useful for efficient overproduction of cloned gene products with NaCl as the inducer. J Bacteriol 179:4403–4406
     [Google Scholar]
  4. Bharti A. R., Nally J. E., Ricaldi J. N., Matthias M. A., Diaz M. M., Lovett M. A., Levett P. N., Gilman R. H., Willig M. R. other authors 2003; Leptospirosis: a zoonotic disease of global importance. Lancet Infect Dis 3:757–771 [CrossRef]
     [Google Scholar]
  5. Branger C., Sonrier C., Chatrenet B., Klonjkowski B., Ruvoen-Clouet N., Aubert A., Andre-Fontaine G., Eloit M. 2001; Identification of the hemolysis-associated protein 1 as a cross-protective immunogen of Leptospira interrogans by adenovirus-mediated vaccination. Infect Immun 69:6831–6838 [CrossRef]
     [Google Scholar]
  6. Bulach D. M., Zuerner R. L., Wilson P., Seemann T., McGrath A., Cullen P. A., Davis J., Johnson M., Kuczek E. other authors 2006; Genome reduction in Leptospira borgpetersenii reflects limited transmission potential. Proc Natl Acad Sci U S A 103:14560–14565 [CrossRef]
     [Google Scholar]
  7. Chang Y. F., Chen C. S., Palaniappan R. U., He H., McDonough S. P., Barr S. C., Yan W., Faisal S. M., Pan M. J. other authors 2007; Immunogenicity of the recombinant leptospiral putative outer membrane proteins as vaccine candidates. Vaccine 25:8190–8197 [CrossRef]
     [Google Scholar]
  8. Cullen P. A., Haake D. A., Bulach D. M., Zuerner R. L., Adler B. 2003; LipL21 is a novel surface-exposed lipoprotein of pathogenic Leptospira species. Infect Immun 71:2414–2421 [CrossRef]
     [Google Scholar]
  9. Cullen P. A., Xu X., Matsunaga J., Sanchez Y., Ko A. I., Haake D. A., Adler B. 2005; Surfaceome of Leptospira spp. Infect Immun 73:4853–4863 [CrossRef]
     [Google Scholar]
  10. De Brito T., Prado M. J., Negreiros V. A., Nicastri A. L., Sakata E. E., Yasuda P. H., Santos R. T., Alves V. A. 1992; Detection of leptospiral antigen ( L. interrogans serovar copenhageni serogroup Icterohaemorrhagiae) by immunoelectron microscopy in the liver and kidney of experimentally infected guinea-pigs. Int J Exp Pathol 73:633–642
     [Google Scholar]
  11. de la Pena-Moctezuma A., Bulach D. M., Kalambaheti T., Adler B. 1999; Comparative analysis of the LPS biosynthetic loci of the genetic subtypes of serovar Hardjo: Leptospira interrogans subtype Hardjoprajitno and Leptospira borgpetersenii subtype Hardjobovis. FEMS Microbiol Lett 177:319–326 [CrossRef]
     [Google Scholar]
  12. Deléage G., Geourjon C. 1993; An interactive graphic program for calculating the secondary structure content of proteins from circular dichroism spectrum. Comput Appl Biosci 9:197–199
     [Google Scholar]
  13. Faine S., Adler B., Bolin C., Perolat P. 1999 Leptospira and Leptospirosis Melbourne, Australia: MediSci;
     [Google Scholar]
  14. Faisal S. M., Yan W., McDonough S. P., Chang C. F., Pan M. J., Chang Y. F. 2009a; Leptosome-entrapped leptospiral antigens conferred significant higher levels of protection than those entrapped with PC-liposomes in a hamster model. Vaccine 27:6537–6545 [CrossRef]
     [Google Scholar]
  15. Faisal S. M., Yan W., McDonough S. P., Mohammed H. O., Divers T. J., Chang Y. F. 2009b; Immune response and prophylactic efficacy of smegmosomes in a hamster model of leptospirosis. Vaccine 27:6129–6136 [CrossRef]
     [Google Scholar]
  16. Finn R. D., Mistry J., Schuster-Bockler B., Griffiths-Jones S., Hollich V., Lassmann T., Moxon S., Marshall M., Khanna A. other authors 2006; Pfam: clans, web tools and services. Nucleic Acids Res 34:D247–D251 [CrossRef]
     [Google Scholar]
  17. Haake D. A., Mazel M. K., McCoy A. M., Milward F., Chao G., Matsunaga J., Wagar E. A. 1999; Leptospiral outer membrane proteins OmpL1 and LipL41 exhibit synergistic immunoprotection. Infect Immun 67:6572–6582
     [Google Scholar]
  18. Juncker A. S., Willenbrock H., Von Heijne G., Brunak S., Nielsen H., Krogh A. 2003; Prediction of lipoprotein signal peptides in Gram-negative bacteria. Protein Sci 12:1652–1662 [CrossRef]
     [Google Scholar]
  19. Kaplan E. L., Meier P. 1958; Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457–481 [CrossRef]
     [Google Scholar]
  20. Ko A. I., Galvao Reis M., Ribeiro Dourado C. M., Johnson W. D. Jr, Riley L. W. 1999; Urban epidemic of severe leptospirosis in Brazil. Salvador Leptospirosis Study Group. Lancet 354:820–825 [CrossRef]
     [Google Scholar]
  21. Koizumi N., Watanabe H. 2004; Leptospiral immunoglobulin-like proteins elicit protective immunity. Vaccine 22:1545–1552 [CrossRef]
     [Google Scholar]
  22. Letunic I., Copley R. R., Pils B., Pinkert S., Schultz J., Bork P. 2006; smart 5: domains in the context of genomes and networks. Nucleic Acids Res 34:D257–D260 [CrossRef]
     [Google Scholar]
  23. Levett P. N. 2001; Leptospirosis. Clin Microbiol Rev 14:296–326 [CrossRef]
     [Google Scholar]
  24. McBride A. J., Athanazio D. A., Reis M. G., Ko A. I. 2005; Leptospirosis. Curr Opin Infect Dis 18:376–386 [CrossRef]
     [Google Scholar]
  25. Medini D., Serruto D., Parkhill J., Relman D. A., Donati C., Moxon R., Falkow S., Rappuoli R. 2008; Microbiology in the post-genomic era. Nat Rev Microbiol 6:419–430
     [Google Scholar]
  26. Nakai K., Horton P. 1999; psort: a program for detecting sorting signals in proteins and predicting their subcellular localization. Trends Biochem Sci 24:34–36 [CrossRef]
     [Google Scholar]
  27. Nakai K., Kanehisa M. 1991; Expert system for predicting protein localization sites in Gram-negative bacteria. Proteins 11:95–110 [CrossRef]
     [Google Scholar]
  28. Nascimento A. L., Verjovski-Almeida S., Van Sluys M. A., Monteiro-Vitorello C. B., Camargo L. E., Digiampietri L. A., Harstkeerl R. A., Ho P. L., Marques M. V. other authors 2004a; Genome features of Leptospira interrogans serovar Copenhageni. Braz J Med Biol Res 37:459–477 [CrossRef]
     [Google Scholar]
  29. Nascimento A. L., Ko A. I., Martins E. A., Monteiro-Vitorello C. B., Ho P. L., Haake D. A., Verjovski-Almeida S., Hartskeerl R. A., Marques M. V. other authors 2004b; Comparative genomics of two Leptospira interrogans serovars reveals novel insights into physiology and pathogenesis. J Bacteriol 186:2164–2172 [CrossRef]
     [Google Scholar]
  30. Palaniappan R. U., McDonough S. P., Divers T. J., Chen C. S., Pan M. J., Matsumoto M., Chang Y. F. 2006; Immunoprotection of recombinant leptospiral immunoglobulin-like protein A against Leptospira interrogans serovar Pomona infection. Infect Immun 74:1745–1750 [CrossRef]
     [Google Scholar]
  31. Palaniappan R. U., Ramanujam S., Chang Y. F. 2007; Leptospirosis: pathogenesis, immunity, and diagnosis. Curr Opin Infect Dis 20:284–292 [CrossRef]
     [Google Scholar]
  32. Picardeau M., Bulach D. M., Bouchier C., Zuerner R. L., Zidane N., Wilson P. J., Creno S., Kuczek E. S., Bommezzadri S. other authors 2008; Genome sequence of the saprophyte Leptospira biflexa provides insights into the evolution of Leptospira and the pathogenesis of leptospirosis. PLoS One 3:e1607 [CrossRef]
     [Google Scholar]
  33. Plank R., Dean D. 2000; Overview of the epidemiology, microbiology, and pathogenesis of Leptospira spp. in humans. Microbes Infect 2:1265–1276 [CrossRef]
     [Google Scholar]
  34. Ren S. X., Fu G., Jiang X. G., Zeng R., Miao Y. G., Xu H., Zhang Y. X., Xiong H., Lu G. other authors 2003; Unique physiological and pathogenic features of Leptospira interrogans revealed by whole-genome sequencing. Nature 422:888–893 [CrossRef]
     [Google Scholar]
  35. Schultz J., Milpetz F., Bork P., Ponting C. P. 1998; smart, a simple modular architecture research tool: identification of signaling domains. Proc Natl Acad Sci U S A 95:5857–5864 [CrossRef]
     [Google Scholar]
  36. Seixas F. K., Fernandes C. H., Hartwig D. D., Conceição F. R., Aleixo J. A., Dellagostin O. A. 2007a; Evaluation of different ways of presenting LipL32 to the immune system with the aim of developing a recombinant vaccine against leptospirosis. Can J Microbiol 53:472–479 [CrossRef]
     [Google Scholar]
  37. Seixas F. K., da Silva E. F., Hartwig D. D., Cerqueira G. M., Amaral M., Fagundes M. Q., Dossa R. G., Dellagostin O. A. 2007b; Recombinant Mycobacterium bovis BCG expressing the LipL32 antigen of Leptospira interrogans protects hamsters from challenge. Vaccine 26:88–95 [CrossRef]
     [Google Scholar]
  38. Serruto D., Rappuoli R. 2006; Post-genomic vaccine development. FEBS Lett 580:2985–2992 [CrossRef]
     [Google Scholar]
  39. Setubal J. C., Reis M., Matsunaga J., Haake D. A. 2006; Lipoprotein computational prediction in spirochaetal genomes. Microbiology 152:113–121 [CrossRef]
     [Google Scholar]
  40. Silva E. F., Medeiros M. A., McBride A. J., Matsunaga J., Esteves G. S., Ramos J. G., Santos C. S., Croda J., Homma A. other authors 2007; The terminal portion of leptospiral immunoglobulin-like protein LigA confers protective immunity against lethal infection in the hamster model of leptospirosis. Vaccine 25:6277–6286 [CrossRef]
     [Google Scholar]
  41. Turner L. H. 1970; Leptospirosis. 3. Maintenance, isolation and demonstration of leptospires. Trans R Soc Trop Med Hyg 64:623–646 [CrossRef]
     [Google Scholar]
  42. Vieira M. L., Atzingen M. V., Oliveira T. R., Oliveira R., Andrade D. M., Vasconcellos S. A., Nascimento A. L. T. O. 2010; In vitro identification of novel plasminogen-binding receptors of the pathogen Leptospira interrogans . PLoS One 5:e11259 [CrossRef]
     [Google Scholar]
  43. Yan W., Faisal S. M., McDonough S. P., Divers T. J., Barr S. C., Chang C. F., Pan M. J., Chang Y. F. 2009; Immunogenicity and protective efficacy of recombinant Leptospira immunoglobulin-like protein B (rLigB) in a hamster challenge model. Microbes Infect 11:230–237 [CrossRef]
     [Google Scholar]
  44. Yan W., Faisal S. M., McDonough S. P., Chang C. F., Pan M. J., Akey B., Chang Y. F. 2010; Identification and characterization of OmpA-like proteins as novel vaccine candidates for leptospirosis. Vaccine 28:2277–2283 [CrossRef]
     [Google Scholar]
  45. Yu C. S., Lin C. J., Hwang J. K. 2004; Predicting subcellular localization of proteins for Gram-negative bacteria by support vector machines based on n -peptide compositions. Protein Sci 13:1402–1406 [CrossRef]
     [Google Scholar]
  46. Yu C. S., Chen Y. C., Lu C. H., Hwang J. K. 2006; Prediction of protein subcellular localization. Proteins 64:643–651 [CrossRef]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.021485-0
Loading
Characterization of leptospiral proteins that afford partial protection in hamsters against lethal challenge with Leptospira interrogans
J. Med. Microbiol. 59, 1005 (2010); https://doi.org/10.1099/jmm.0.021485-0
/content/journal/jmm/10.1099/jmm.0.021485-0
/content/journal/jmm/10.1099/jmm.0.021485-0
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error